Source: Annual Congress 2006 - Recent advances in the treatment of asthma and allergic rhinitis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Kottakis, A. Nandeuil, H. Raptis, A. Savu, S. E. Linberg, A. A. Woodcock (Parma, Italy; Courbevoie, France; Bucharest, Romania; Rockville, United States Of America; Manchester, United Kingdom). Efficacy of the novel very long-acting β2-agonist carmoterol following 7 days once daily dosing: comparison with twice daily formoterol in patient with persistent asthma. Eur Respir J 2006; 28: Suppl. 50, 3858

Member's Comments

No comment yet.

Related content which might interest you: Safety and tolerability of the novel very long acting β2-agonist Carmoterol given as a 2μg qd dose; 8 days comparison with formoterol and placebo in patients with persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 665s Year: 2006 Superior efficacy of a low daily dose of a new fixed combination of beclometasone dipropionate/formoterol pMDI compared to an increased daily dose of BDP in moderate persistent asthma: a 3 month clinical study Source: Eur Respir J 2006; 28: Suppl. 50, 207s Year: 2006 Comparable efficacy and tolerability of formoterol 12 μg or 24 μg twice daily in asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005 A comparison of the efficacy of low dose single inhaler budesonide/formoterol given once and twice daily in patients with mild- to- moderate asthma Source: Eur Respir J 2007; 30: Suppl. 51, 615s Year: 2007 Comparable efficacy of ciclesonide 160 μg once daily and budesonide 200 μg twice daily in patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005 Once daily ciclesonide and twice daily fluticasone propionate are equally effective in the treatment of patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004 Once daily ciclesonide (80 µg or 320 µg) is equally effective as budesonide 200 µg given twice daily: a 12-week study in asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 410s Year: 2003 Effects of esomeprazole 40 mg twice-daily in adults with moderate to severe asthma who had been treated previously with inhaled steroids and long-acting β2-agonists Source: Eur Respir J 2005; 26: Suppl. 49, 278s Year: 2005 Superior bronchodilation of once daily tiotropium compared to twice daily salmeterol in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 26s Year: 2001 Single dose of of tiotropium bromide (18 mcg) produces a similar bronchodilator response as two doses of formoterol fumarate (12 mcg ) over 24 hours in subjects with moderate-to-severe asthma Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma, and comparison with formoterol Source: Annual Congress 2008 - New treatments for asthma Year: 2008 Scientific rationale for using a single inhaler for asthma control by comparison of the effectiveness and safety of formoterol/budesonide turbuhaler as physician-guided adjustable maintenance dosing regimen versus formoterol/budesonide given as fixed dose of twice daily therapy in the management of bronchial asthma Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Inhaled budesonide 800 μg once daily versus 400 μg twice daily in patients with mild-to-moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 97s Year: 2001 Superior spirometric efficacy of single dose formoterol compared to single dose salmeterol during the first hour post-dose in moderate and severe COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 57s Year: 2001 Comparison of ciclesonide (MDI) once daily and fluticasone propionate (Diskus®) twice daily in the treatment of patients with moderate asthma Source: Eur Respir J 2006; 28: Suppl. 50, 666s Year: 2006 Formoterol Turbuhaler® twice daily is more cost-effective than salmeterol twice daily or as-needed salbutamol Source: Eur Respir J 2001; 18: Suppl. 33, 330s Year: 2001 The effect of esomeprazole 40mg once or twice daily on asthma outcome Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Comparison of 800 μg once vs. 400 μg twice daily inhaled budesonide in patients with moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 49s Year: 2001 No evidence for increase in serious asthma exacerbations with formoterol 24 μg twice daily Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005 Acute asthma treatment: comparison of formoterol and salbutamol given in cumulative doses in children Source: Eur Respir J 2001; 18: Suppl. 33, 122s Year: 2001